Pharmaceutical Measures to Prevent Doxorubicin-Induced Cardiotoxicity

E-ISSN： 1875-5607|17|1|44-50

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.17, Iss.1, 2017-01, pp. : 44-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A concise description of cardioprotective strategies in doxorubicin-induced cardiotoxicity

By Lehenbauer Ludke Ana R. Al-Shudiefat Abd Al-Rahman S. Dhingra Sanjiv Jassal Davinder S. Singal Pawan K.

Canadian Journal of Physiology and Pharmacology, Vol. 87, Iss. 10, 2009-10 ,pp. : 756-763

NRC Research Press

Access to resources Recommend Favorite

Berberine Attenuates Doxorubicin-induced Cardiotoxicity in Mice

By Zhao X Zhang J Tong N Liao X Wang E Li Z Luo Y Zuo H

The Journal of International Medical Research, Vol. 39, Iss. 5, 2011-09 ,pp. : 1720-1727

Field House Publishing

Access to resources Recommend Favorite

Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats

By Ammar El-Sayed M. Said Shehta A. Suddek Ghada M. El-Damarawy Sally L.

Canadian Journal of Physiology and Pharmacology, Vol. 89, Iss. 4, 2011-04 ,pp. : 269-276

NRC Research Press

Access to resources Recommend Favorite

Reduction of Doxorubicin-Induced Cardiotoxicity Using Nanocarriers: A Review

Current Drug Metabolism, Vol. 18, Iss. 3, 2017-03 ,pp. : 237-263

Bentham Science Publishers

Access to resources Recommend Favorite

Alternative Approach for Mitigation of Doxorubicin-Induced Cardiotoxicity using Herbal Agents

Current Clinical Pharmacology, Vol. 9, Iss. 3, 2014-08 ,pp. : 288-297

Bentham Science Publishers

Access to resources Recommend Favorite